MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ymgmr.2022.100870

Медицинская библиотека · Molecular genetics and metabolism reports · 2022

Neuropsychiatric and sleep study in autosomal dominant dopa-responsive dystonia.

Alves Júnior Ailton C, Daker Maurício V, Machado Alexei M C, Luna Alan S, Valladares Neto Dirceu C, Valadares Eugenia R

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Although the diurnal fluctuation of motor dysfunction, reversible with small doses of dopamine, is a cornerstone for the phenotype of the autosomal dominant Segawa syndrome, the non-motor symptoms of this neurotransmitter deficiency have still received limited attention.

OBJECTIVE

This study aims to evaluate non-motor symptoms of this dopa-responsive dystonia through an intrafamilial comparative cross-sectional study.

METHODS

Seventeen individuals with a c.IVS5 + 3insT (c.626 + 3insT) variation in the GTP cyclohydrolase-1 gene (GCH1, HGNC: 4193) and 34 intrafamilial controls were studied using the Beck Depression Inventory-II, the Wiener Matrizen Test 2, the Epworth Sleepiness Scale, the Pittsburgh Sleep Quality Index, the MINI/MINI PLUS Questionnaires, the World Health Organization Quality of Life - BREF Instrument and a drug use assessment questionnaire.

RESULTS

No significant difference was found between the groups in the prevalence of sleep disorders and in cognitive function. Nevertheless, generalized anxiety disorder (p = 0.050) and attention-deficit/hyperactivity disorder in childhood (p = 0.011) were observed only in individuals without the molecular variation. The group with the GCH1 variation presented a worse perception about how safe they feel in their daily lives (p = 0.034), less satisfaction with themselves (p = 0.049) and with their relationships (p = 0.029), and a higher prevalence of past major depressive episodes before use of L-Dopa (p = 0.046).

CONCLUSION

Low dopamine could have been protective against generalized anxiety disorder and attention-deficit/hyperactivity disorder in childhood in Segawa group individuals. The prevalence of depression was higher in individuals with the molecular variant prior to the L-Dopa treatment. Considering it, the penetrance estimates for the variant carriers increased from 58.8% to up to 88% in this large studied family. Additionally, neuropsychiatric tests of all individuals with a molecular diagnosis in an affected family are a valuable instrument for its clinical management.

Для цитирования: Alves Júnior Ailton C, Daker Maurício V, Machado Alexei M C, Luna Alan S, Valladares Neto Dirceu C, Valadares Eugenia R. Neuropsychiatric and sleep study in autosomal dominant dopa-responsive dystonia.. Molecular genetics and metabolism reports. 2022. DOI: 10.1016/j.ymgmr.2022.100870.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.